MD3121F1 - Method of viral hepatitis B prophylaxis - Google Patents
Method of viral hepatitis B prophylaxisInfo
- Publication number
- MD3121F1 MD3121F1 MDA20050280A MD20050280A MD3121F1 MD 3121 F1 MD3121 F1 MD 3121F1 MD A20050280 A MDA20050280 A MD A20050280A MD 20050280 A MD20050280 A MD 20050280A MD 3121 F1 MD3121 F1 MD 3121F1
- Authority
- MD
- Moldova
- Prior art keywords
- viral hepatitis
- prophylaxis
- vaccine
- pacovirin
- tablets
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention refers to medicine, in particular to the infectious diseases and may be used for viral hepatitis B prophylaxis. Summary of the invention consists in that it is administered the viral hepatitis B vaccine and Pacovirin preparation in tablets, in a dose of 50,0 mg of active substance, during 90 days from the day of administration of the vaccine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20050280A MD3121G2 (en) | 2005-09-15 | 2005-09-15 | Method of viral hepatitis B prophylaxis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20050280A MD3121G2 (en) | 2005-09-15 | 2005-09-15 | Method of viral hepatitis B prophylaxis |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3121F1 true MD3121F1 (en) | 2006-08-31 |
MD3121G2 MD3121G2 (en) | 2007-03-31 |
Family
ID=36992845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20050280A MD3121G2 (en) | 2005-09-15 | 2005-09-15 | Method of viral hepatitis B prophylaxis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3121G2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD223Z (en) * | 2010-03-05 | 2011-02-28 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method for revaccination of children against viral hepatitis B |
MD4177C1 (en) * | 2011-01-14 | 2013-02-28 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for vaccination against hepatitis B of persons with immunodeficiency |
MD596Z (en) * | 2012-10-09 | 2013-09-30 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for treating chronic viral hepatitis C in children |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD670G2 (en) * | 1996-05-08 | 1997-08-31 | Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova | Remedy with immunomodulator activity |
MD1875G2 (en) * | 1999-11-01 | 2002-09-30 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of treatment of the acute viral hepatitis B |
MD2053C2 (en) * | 2001-07-10 | 2003-07-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remedy with interferon inducing action |
MD2549G2 (en) * | 2003-07-18 | 2005-08-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of treatment of the chronic viral hepatitis C |
-
2005
- 2005-09-15 MD MDA20050280A patent/MD3121G2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD3121G2 (en) | 2007-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD4430C1 (en) | Compositions and methods for treating hepatitis C virus | |
MX2012007410A (en) | Novel antiviral compounds. | |
TW200630093A (en) | Dose forms | |
UY30537A1 (en) | FLIBANSERIN FORMULATIONS AND METHOD TO MANUFACTURE THEM | |
EA200701519A1 (en) | LIVE ATTENUATED ROTAVIRAL VACCINE FOR ORAL ADMINISTRATION | |
MY154683A (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
WO2010116385A3 (en) | Pharmaceutical compositions for alleviating unpleasant taste | |
SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
WO2006044968A3 (en) | Combination therapy for treating viral infections | |
EA200800467A1 (en) | APPLICATION OF COMPLEX ETHERS OF HYDROXYBENZOIC ACID AND ANALOGUES FOR OBTAINING MEDICINES FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTION | |
PA8744101A1 (en) | METHOD OF COMBINED THERAPY FOR THE TREATMENT OF INFECTION BY THE VIRUS OF HEPATITIS C AND PHARMACEUTICAL COMPOSITIONS FOR USE IN SUCH THERAPY | |
WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
AR045289A1 (en) | ORAL DOSAGE FORM OF CONTROLLED RELEASE THAT INCLUDES 4- (2-DI-N-PROPILAMINOETIL) - 2 (3H) -INDOLONE (ROPI-NIROL) AND USE OF SUCH DOSAGE FORM FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
ES2570401T3 (en) | Methods of treatment using single doses of oritavancin | |
MX2022006742A (en) | Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives. | |
AR048318A1 (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
GT200600263A (en) | DOSAGE REGIME FOR PRASUGREL | |
MX2013003523A (en) | Low dose pharmaceutical composition comprising zanamivir. | |
MD3121G2 (en) | Method of viral hepatitis B prophylaxis | |
MY166524A (en) | Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy | |
MX2017005163A (en) | Onapristone extended-release compositions and methods. | |
TW200618807A (en) | Prevention and therapeutical agent for hepatitis C virus infection | |
MD20060037A (en) | Method of treating the acute viral hepatitis C | |
RU2013120345A (en) | NEW METHODS FOR TREATING INFECTIONS CAUSED BY HEPATITIS C VIRUS | |
JP2020536098A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |